Table III.
Proportions of TregFoxP3+ and Th17 ( ± s,%) and the TregFoxP3+/Th17 ratio of the healthy control group and the NSCLC group
Variable | Healthy control group (n = 18) | NSCLC group (n = 26) | Value of p |
---|---|---|---|
TregFoxP3+ | 3.65 ±0.97 | 7.02 ±2.41 | < 0.05 |
Th17 | 2.21 ±0.64 | 3.61 ±0.82 | < 0.05 |
TregFoxP3+/Th17 | 1.54 ±0.45 | 1.92 ±0.51 | < 0.05 |